Drug Shortage Report for VENLAFAXINE XR

Last updated on 2019-06-08 History
Report ID 72114
Drug Identification Number 02385945
Brand name VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR
Company Name SIVEM PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 150MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 500
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-03-04
Actual start date 2019-02-26
Estimated end date 2019-06-07
Actual end date 2019-06-07
Shortage status Resolved
Updated date 2019-06-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2019-06-08 English Compare
v21 2019-06-07 French Compare
v20 2019-06-07 English Compare
v19 2019-05-17 French Compare
v18 2019-05-17 English Compare
v17 2019-05-13 French Compare
v16 2019-05-13 English Compare
v15 2019-05-06 French Compare
v14 2019-05-06 English Compare
v13 2019-03-25 French Compare
v12 2019-03-25 English Compare
v11 2019-03-12 French Compare
v10 2019-03-12 English Compare
v9 2019-03-11 French Compare
v8 2019-03-11 English Compare
v7 2019-03-05 English Compare
v6 2019-02-01 French Compare
v5 2019-02-01 English Compare
v4 2019-01-28 French Compare
v3 2019-01-28 English Compare

Showing 1 to 20 of 22